删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

The synergistic role of Pu.1 and Fms in zebrafish osteoclast-reducing osteopetrosis and possible the

本站小编 Free考研考试/2022-01-01

Wei Liua,
Qianqian Dib,
Kailun Lia,
Jing Lib,
Ning Mab,
Zhibin Huanga,
Jiahao Chena,
Sheng Zhangc,
Wenqing Zhanga,
Yiyue Zhanga
aDivision of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou, 510006, China
bKey Laboratory of Zebrafish Modeling and Drug Screening for Human Diseases of Guangdong Higher Education Institutes, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China
cDepartment of Orthopedics and Traumatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China

More InformationCorresponding author: E-mail address: mczhangwq@scut.edu.cn (Wenqing Zhang);E-mail address: mczhangyy@scut.edu.cn (Yiyue Zhang)
Publish Date:2020-09-25




Abstract
Osteoclasts are bone resorption cells of myeloid origin. Osteoclast defects can lead to osteopetrosis, a genetic disorder characterized by bone sclerosis for which there is no effective drug treatment. It is known that Pu.1 and Fms are key regulators in myelopoiesis, and their defects in mice can lead to reduced osteoclast numbers and consequent osteopetrosis. Yet?how Pu.1 and Fms genetically interact in the development of osteoclasts and the pathogenesis of osteopetrosis is still unclear. Here, we characterized pu.1;fms double-deficient zebrafish, which exhibited a greater deficiency of functional osteoclasts and displayed more severe osteopetrotic symptoms than the pu.1 or fms single mutants, suggesting a synergistic function of Pu.1 and Fms in the regulation of osteoclast development. We further demonstrated that Pu.1 plays a dominant role in osteoclastogenesis, whereas Fms plays a dominant role in osteoclast maturation. Importantly, treatment with the drug retinoic acid significantly relieved the different degrees of osteopetrosis symptoms in these models by increasing the number of functional osteoclasts. Thus, we report the development of valuable animal models of osteopetrosis, and our results shed light on drug development for antiosteopetrosis therapy.
Keywords: Zebrafish,
Bone development,
Osteoclasts,
Osteopetrosis,
Therapeutics



PDF全文下载地址:

http://www.jgenetgenomics.org/article/exportPdf?id=1a3b7412-b149-468e-8ed7-ebe47d8b05a2&language=en
相关话题/synergistic zebrafish osteoclastreducing